Article Per Year (5 Year)
p-Index From 2021 - 2026
0.408
P-Index
This Author published in this journals
All Journal Jurnal Health Sains Research Horizon
Wiyardhani, Laras
Unknown Affiliation
Arts Humanities Dentistry Economics, Econometrics & Finance Education Health Professions Law, Crime, Criminology & Criminal Justice Medicine & Pharmacology Nursing Public Health Social Sciences Veterinary

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Legal Protection for Consumers Against Hazardous Skincare Products Wiyardhani, Laras; Wibriansyah, Akbar; Payuti, Yuyut
Research Horizon Vol. 5 No. 3 (2025): Research Horizon - June 2025
Publisher : LifeSciFi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.54518/rh.5.3.2025.658

Abstract

The proliferation of unregistered skincare products in Indonesia presents a critical legal issue concerning consumer safety and regulatory enforcement. Despite the presence of Law Number 8 of 1999 on Consumer Protection, the circulation of unauthorized cosmetics continues to endanger public health and disrupt market order, as evidenced by national agency of drug and food control 2024 data reporting over 1,000 confiscated illegal products valued in the tens of billions of rupiah. This research addresses the legal question of how effectively current consumer protection laws safeguard individuals from the risks posed by illegal skincare products. The study aims to analyze the normative foundation of consumer protection, evaluate enforcement challenges, and propose strategies to enhance regulatory efficacy. Using a normative juridical method, the research relies on statutory analysis, case studies, and conceptual interpretation based on primary, secondary, and tertiary legal sources. The findings reveal that although the legal framework is normatively adequate, its implementation is hindered by low public awareness, limited digital oversight, and fragmented institutional coordination. The study concludes by recommending integrated digital supervision, strengthened inter-agency collaboration, and continuous consumer legal education as essential measures to reinforce legal protection and curb the spread of unauthorized skincare products in Indonesia.
Comparison of the of Operative Treatment and Sclerotherapy Injection in the Management of Hemorrhoids: A Meta-Analysis of Randomized Controlled Trials Wiyardhani, Laras; Sander, Tara; Wibriansyah, Akbar
Jurnal Health Sains Vol. 6 No. 9 (2025): Journal Health Sains
Publisher : Syntax Corporation Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.46799/jhs.v6i9.2695

Abstract

Rubber-band ligation (RBL) and sclerotherapy are the two most widely used office-based interventions for symptomatic haemorrhoidal disease, yet their comparative benefits remain uncertain. This systematic review and meta-analysis evaluated the relative efficacy and safety of sclerotherapy versus operative treatments (primarily RBL and excisional procedures). The primary objective of this systematic review and meta-analysis was to evaluate the relative efficacy and safety of sclerotherapy versus operative treatments (primarily RBL and excisional procedures) in the management of hemorrhoidal disease. Treatment success was 78.2% in operative arms (701/896) versus 74.1% with sclerotherapy (665/897); pooled RR = 1.03 (95% CI 0.91–1.17; I² = 85%), indicating non-inferiority of sclerotherapy. Recurrence in two trials (n = 302) showed lower recurrence after sclerotherapy (12.9%) than after operative treatment (28.4%); RR = 2.22 (95% CI 1.37–3.58; I² = 0%). Pain in three trials (n = 335) reported a higher risk of significant pain following operative procedures (RR = 1.17, 95% CI 1.02–1.34; I² = 60%) and greater mean pain intensity (SMD = 0.96, 95% CI 0.22–1.71; I² = 89%). Sclerotherapy achieves comparable short-term symptom control to operative treatments while offering superior durability and a more favorable pain profile. Given its minimal invasiveness and ease of repetition, modern sclerotherapy should be considered a first-line option for grade I–III haemorrhoids. High between-study heterogeneity underscores the need for standardized protocols and longer follow-up.
Co-Authors Akbar Wibriansyah Payuti, Yuyut Sander, Tara